QXJ-19683-25319 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-24
Registered in v-safe
2020-12-24
Dose 1 — Pfizer-BioNTech
2020-12-24
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2020-12-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Swelling · None

Adult check-in
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-29
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-30
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-31
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-07
Survey response — day 14, dose 1
MedDRA: Pregnancy — Feeling: Good

Free text: Pregnancy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-25
Survey response — 3 months, dose 1
MedDRA: Gestational trophoblastic tumour — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: GEstational Trophoblastic Neoplasia

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-25
Report sent to call center — 3 months, dose 1
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-04-09
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-24	Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 1 — day 14, dose 1

2021-01-07

Symptoms: Pregnancy

Release 6 — 3 months, dose 1

2021-03-25

Symptoms: GEstational Trophoblastic Neoplasia

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Exposure during pregnancy	○	○	○
SD	Gestational trophoblastic tumour	✓	✓	✓
SD	Pregnancy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release